Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M21,191Revenue $M1,421Net Margin (%)8.8Z-Score9.6
Enterprise Value $M20,948EPS $0.9Operating Margin %9.4F-Score6
P/E(ttm))115Cash Flow Per Share $2.3Pre-tax Margin (%)11.2Higher ROA y-yY
Price/Book13.610-y EBITDA Growth Rate %0Quick Ratio1.3Cash flow > EarningsY
Price/Sales16.15-y EBITDA Growth Rate %15.2Current Ratio1.4Lower Leverage y-yY
Price/Cash Flow22.7y-y EBITDA Growth Rate %55.8ROA % (ttm)4.2Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)8.2Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M128ROI % (ttm)4.0Gross Margin Increase y-yN

Gurus Latest Trades with ILMN

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ILMNGeorge Soros 2014-03-31 Add0.06%$108.61 - $179.54
($149.79)
$ 165.0410%Add 395.96%50,102
ILMNMario Gabelli 2014-03-31 Reduce$108.61 - $179.54
($149.79)
$ 165.0410%Reduce -36.97%10,400
ILMNRon Baron 2014-03-31 Reduce-0.23%$108.61 - $179.54
($149.79)
$ 165.0410%Reduce -22.81%1,705,740
ILMNMario Gabelli 2013-09-30 Reduce$73.36 - $85.34
($78.64)
$ 165.04110%Reduce -24.49%18,500
ILMNGeorge Soros 2013-09-30 Reduce-0.01%$73.36 - $85.34
($78.64)
$ 165.04110%Reduce -59.59%10,102
ILMNRon Baron 2013-06-30 Add0.37%$54.24 - $74.95
($65.8)
$ 165.04151%Add 77.99%2,164,898
ILMNMario Gabelli 2013-06-30 Reduce$54.24 - $74.95
($65.8)
$ 165.04151%Reduce -25.08%24,500
ILMNJohn Hussman 2013-06-30 Sold Out -0.79%$54.24 - $74.95
($65.8)
$ 165.04151%Sold Out0
ILMNGeorge Soros 2013-06-30 Reduce-0.01%$54.24 - $74.95
($65.8)
$ 165.04151%Reduce -37.5%25,000
ILMNVanguard Health Care Fund 2013-03-31 Buy 0.48%$48.36 - $55.59
($51.74)
$ 165.04219%New holding, 2240200 sh.2,240,200
ILMNGeorge Soros 2013-03-31 Buy 0.03%$48.36 - $55.59
($51.74)
$ 165.04219%New holding, 40000 sh.40,000
ILMNDaniel Loeb 2013-03-31 Sold Out -1.5%$48.36 - $55.59
($51.74)
$ 165.04219%Sold Out0
ILMNJohn Hussman 2013-03-31 Reduce-0.9%$48.36 - $55.59
($51.74)
$ 165.04219%Reduce -60%400,000
ILMNJohn Burbank 2013-03-31 Sold Out -0.01%$48.36 - $55.59
($51.74)
$ 165.04219%Sold Out0
ILMNDaniel Loeb 2012-12-31 Buy 1.5%$45.19 - $56.39
($50.67)
$ 165.04226%New holding, 1500000 sh.1,500,000
ILMNJohn Hussman 2012-12-31 Add0.55%$45.19 - $56.39
($50.67)
$ 165.04226%Add 57.73%1,000,000
ILMNJohn Burbank 2012-12-31 Buy 0.21%$45.19 - $56.39
($50.67)
$ 165.04226%New holding, 100000 sh.100,000
ILMNPRIMECAP Management 2012-12-31 Add0.07%$45.19 - $56.39
($50.67)
$ 165.04226%Add 60.44%2,076,200
ILMNJoel Greenblatt 2012-12-31 Sold Out -0.03%$45.19 - $56.39
($50.67)
$ 165.04226%Sold Out0
ILMNRon Baron 2012-09-30 Add0.22%$39.41 - $48.48
($42.96)
$ 165.04284%Add 130.47%1,242,007
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ILMN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ILMN Vanguard Health Care Fund 2014-06-302,160,5001.681
ILMN George Soros 2014-03-3150,1020.040.07+395.96%
ILMN PRIMECAP Management 2014-03-312,262,2701.760.38+10.46%
ILMN Jean-Marie Eveillard 2014-03-3140000
ILMN Ron Baron 2014-03-311,705,7401.331-22.81%
ILMN Mario Gabelli 2014-03-3110,4000.010.01-36.97%
Premium Most recent portfolio changes are included for Premium Members only!


ILMN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BOWMAN A BLAINEDirector 2014-07-29Sell5,000$166.89-1.11view
HENRY CHRISTIAN OSr VP & Chief Commercial Offic 2014-07-29Sell10,000$167.4-1.41view
Dadswell CharlesSr VP & General Counsel 2014-07-28Sell144$171-3.49view
FLATLEY JAY TCEO 2014-07-24Sell30,000$175.43-5.92view
BRADBURY DANIELDirector 2014-07-23Sell2,100$177.87-7.21view
HENRY CHRISTIAN OSr VP & Chief Commercial Offic 2014-07-15Sell20,000$174.09-5.2view
Naclerio NicholasSr VP, Corp Development 2014-07-15Sell2,000$174.26-5.29view
Stapley MarcSr VP & CFO 2014-07-14Sell1,422$177.59-7.07view
FLATLEY JAY TCEO 2014-07-10Sell30,000$172.56-4.36view
BRADBURY DANIELDirector 2014-07-08Sell2,100$172.89-4.54view

Press Releases about ILMN :

Quarterly/Annual Reports about ILMN:

News about ILMN:

Articles On GuruFocus.com
Top Insider Sells Highlight: Illumina Inc. Jul 25 2014 
Weekly CFO Sells Highlight: Envision Healthcare Holdings Inc, Google Inc, Illumina Inc. Jul 20 2014 
Baron Funds Comments on Illumina Inc. May 29 2014 
Baron Funds Comments on Illumina Inc. May 21 2014 
Baron Funds Comments on Illumina Inc. May 12 2014 
Baron Funds Comments on Illumina Inc. May 02 2014 
Weekly 52-Week Highs Highlight: SHPG, ILMN, UA, WDAY Feb 23 2014 
Illumina Inc: How Long Can a Miracle Go On? Feb 07 2014 
Baron Funds Comments on Illumina Inc. Aug 08 2013 
Baron Funds Comments on Illumina Inc. Aug 02 2013 


More From Other Websites
Celgene, Alexion Beat Estimates, But Biotechs Fall Jul 24 2014
Stock Indexes Nearly Flat, But Apparel, Paper, Internet Shine Jul 24 2014
Under Armour, Facebook Soar As Nasdaq Turns Positive Jul 24 2014
Illumina (ILMN) Tops Q2 Earnings & Revenues, Ups Guidance Jul 24 2014
Illumina price target raised to $195 from $180 at Leerink Jul 24 2014
Illumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2014 Jul 23 2014
Illumina Inc Earnings Call scheduled for 5:00 pm ET today Jul 23 2014
ILLUMINA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Jul 23 2014
Illumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2014 Jul 23 2014
Q2 2014 Illumina, Inc. Earnings Release - After Market Close Jul 23 2014
Sidra to Help Qatar Grow as a Hub for Genetic Medicine Jul 22 2014
Ark’s Wood Says Athena a ‘Fall Through Cracks’ Stock (Audio) Jul 22 2014
How A Giant Act Of Philanthropy May Kickstart Psychiatry Jul 22 2014
Sidra to Help Qatar Grow as a Hub for Genetic Medicine Jul 22 2014
Berry Genomics and Illumina Co-Develop Integrated Next-Generation Sequencing System for Review and... Jul 21 2014
Berry Genomics and Illumina Co-Develop Integrated Next-Generation Sequencing System for Review and... Jul 21 2014
Berry Genomics and Illumina Co-Develop Integrated Next-Generation Sequencing System for Review and... Jul 21 2014
An Unsolicited Comment On Janet Yellen's Biotech Comments Jul 17 2014
Illumina Acquires Myraqa, a Leading IVD and Companion Diagnostic Consulting Firm Jul 16 2014
Illumina acquires Myraqa Jul 16 2014

Add Notes, Comments or Ask Questions

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide